XML 1044 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Options and Warrants to Purchase Common Stock
6 Months Ended 12 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Notes to Financial Statements    
Options And Warrants To Purchase Common Stock [Text Block]
NOTE
9–
OPTIONS AND WARRANTS TO PURCHASE COMMON STOCK
 
Outstanding Stock Warrants
 
A summary of the status and changes of the warrants issued for the
six
months ended
2018:
 
   
Shares Issuable
upon exercise of
         
   
upon Exercise of
   
Weighted Average
 
   
Outstanding
Warrants
   
Exercise Price
 
                 
Outstanding at January 1, 2018
   
18,813,373
    $
0.14
 
Issued
   
8,000,000
    $
0.15
 
Exercised
   
(2,000,000
)
  $
0.04
 
Forfeited
   
--
     
--
 
Outstanding at June 30, 2018
   
24,813,373
    $
0.15
 
 
A summary of the status of the warrants outstanding and exercisable at
June 30, 2018
is presented below:
 
 
 
 
 
Warrants Outstanding and Exercisable
 
 
 
 
 
Shares Issuable
 
 
Weighted Average
 
 
 
 
 
 
 
 
 
upon Exercise of
 
 
Remaining
 
 
Weighted Average
 
Exercise Price
 
 
Outstanding Warrants
 
 
Contractual Life (years)
 
 
Exercise Price
 
$
1.15
 
 
 
461,340
 
 
 
2.8
 
 
$
1.15
 
$
0.25
 
 
 
3,283,283
 
 
 
3.0
 
 
$
0.25
 
$
0.04
 
 
 
2,068,750
 
 
 
4.3
 
 
$
0.04
 
$
0.10
 
 
 
11,000,000
 
 
 
4.5
 
 
$
0.10
 
$
0.15
     
8,000,000
     
3.0
   
$
0.15
 
 
 
 
 
 
24,813,373
 
 
 
5.2
 
 
$
0.15
 
 
Outstanding Stock Options
On
November 20, 2012,
the shareholders of the Company approved the adoption of the Applied Minerals, Inc.
2012
Long-Term Incentive Plan (“LTIP”) and the Short-Term Incentive Plan (“STIP”) and the performance criteria used in setting performance goals for awards intended to be performance-based. Under the LTIP,
8,900,000
shares are authorized for issuance. The STIP does
not
refer to a particular number of shares under the LTIP, but would use the shares authorized in the LTIP for issuance under the STIP. The CEO, the CFO, and named executive officers, and directors, among others are eligible to participate in the LTIP and STIP. Prior to the adoption of the LTIP and STIP, stock options were granted under individual arrangements between the Company and the grantees, and approved by the Board of Directors.
 
In
May, 2016,
the Company adopted the
2016
Long-Term Incentive Plan (
“2016
LTIP”). The number of shares of common stock for issuance or for reference purposes subject to the
2016
LTIP was
2,000,000.
 
On
December 7, 2016,
the stockholders of the Company approved the
2016
Incentive Plan. The purpose of the
2016
Incentive Plan is to enhance the profitability and value of the Company for the benefit of its stockholders by enabling the Company to offer eligible employees, consultants, and non-employee directors incentive awards in order to attract, retain and reward such individuals and strengthen the mutuality of interests between such individuals and the Company’s stockholders. The aggregate number of shares of Common Stock that
may
be issued or used for reference purposes under the
2016
Incentive Plan or with respect to which awards
may
be granted
may
not
exceed 
15,000,000
shares, which
may
be either (i) authorized and unissued Common Stock or (ii) Common Stock held in or acquired for the treasury of the Company.
 
The Compensation Committee of the Company Board of Directors has full authority to administer and interpret the
2016
Incentive Plan, to grant awards under the
2016
Incentive Plan, to determine the persons to whom awards will be granted, to determine the types of awards to be granted, to determine the terms and conditions of each award, to determine the number of shares of Common Stock to be covered by each award and to make all other determinations in connection with the
2016
Incentive Plan and the awards thereunder as the Committee, in its sole discretion, deems necessary or desirable.
 
On
December 14, 2017,
the Board of Directors approved the
2017
Incentive Plan (
“2017
IP”). Forty million (
40,000,000
) shares of Common Stock are subject to the
2017
IP.
 
The fair value of each of the Company's stock option awards is estimated on the date of grant using the Black-Scholes option-pricing model that uses the assumptions noted in the table below. Expected volatility is based on an average of historical volatility of the Company's common stock. The risk-free interest rate for periods within the contractual life of the stock option award is based on the yield curve of a
zero
-coupon U.S. Treasury Bond on the date the award is granted with a maturity equal to the expected term of the award.
 
The significant assumptions relating to the valuation of the Company's options granted during the
six
months ended
June 30, 2018
were as follows on a weighted average basis:
 
Dividend Yield
 
 
0%
 
 
Expected Life (in years)
 
2.48
2.96
 
Expected Volatility
 
163.73%
177.59%
 
Risk Free Interest Rate
 
2.54%
2.62%
 
 
A summary of the status and changes of the options granted under stock option plans and other agreements during the
six
months ended
June 30, 2018:
 
   
Shares Issuable
   
Weighted
 
   
Upon Exercise of
   
Average
 
   
Options
   
Exercise Price
 
                 
Outstanding at December 31, 2017
   
57,057,768
    $
0.36
 
Granted
   
4,224,999
    $
0.11
 
Exercised
   
--
     
--
 
Forfeited
   
(232,645
)
   
1.36
 
Outstanding at June 30, 2018
   
61,050,122
    $
0.34
 
 
During the
six
months ended
June 30, 2018,
the Company granted
4,224,999
options to purchase the Company’s common stock with a weighted average exercise price of
$0.11.
The options vest monthly through
June, 2019.
 
 
A summary of the status of the options outstanding at
June 30, 2018
is presented below:
 
Options Outstanding
   
Options Exercisable
 
Number Outstanding
   
 
Weighted
Average
Remaining
Contractual
Life (years)
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Exercise
Price
 
                                   
35,322,222      
9.34
    $
0.06
     
26,697,225
    $
0.06
 
545,289      
9.48
    $
0.075
     
408,968
    $
0.075
 
377,777      
4.93
    $
0.11
     
69,444
    $
0.11
 
3,000,000      
4.61
    $
0.12
     
1,000,000
    $
0.12
 
500,000      
3.13
    $
0.16
     
500,000
    $
0.16
 
81,395      
5.64
    $
0.21
     
81,395
    $
0.21
 
100,000      
2.22
    $
0.22
     
100,000
    $
0.22
 
1,066,155      
2.87
    $
0.24
     
1,066,155
    $
0.24
 
2,087,500      
4.29
    $
0.25
     
2,087,500
    $
0.25
 
35,595      
4.79
    $
0.27
     
35,595
    $
0.27
 
474,815      
5.86
    $
0.28
     
474,815
    $
0.28
 
234,506      
4.64
    $
0.285
     
234,506
    $
0.285
 
81,522      
2.56
    $
0.30
     
81,522
    $
0.30
 
200,000      
6.63
    $
0.66
     
200,000
    $
0.66
 
150,000      
6.61
    $
0.68
     
150,000
    $
0.68
 
7,233,277      
0.50
    $
0.70
     
7,233,277
    $
0.70
 
488,356      
6.89
    $
0.73
     
488,356
    $
0.73
 
3,104,653      
3.65
    $
0.83
     
3,104,653
    $
0.83
 
975,000      
5.95
    $
0.84
     
975,000
    $
0.84
 
300,000      
5.14
    $
1.10
     
300,000
    $
1.10
 
300,000      
4.99
    $
1.15
     
300,000
    $
1.15
 
115,000      
2.74
    $
1.35
     
115,000
    $
1.35
 
300,000      
3.90
    $
1.55
     
300,000
    $
1.55
 
3,077,060      
4.39
    $
1.66
     
3,077,060
    $
1.66
 
900,000      
3.14
    $
1.90
     
900,000
    $
1.90
 
61,050,122      
6.82
    $
0.34
     
49,980,471
    $
0.40
 
 
On
December 14, 2017,
the Company’s management was granted performance-based options to purchase
27.5
million shares of the Company’s common stock at
$0.06
per share. The options expire on
December 13, 2027.
At
December 31, 2017,
the
first
fifty
percent (
50%
) of the performance-based options vested as management was able to (i) close the sale of an aggregate of
$600,000
of units (consisting of a share of common stock of the Company and a warrant to buy
0.25
of a share of common stock of the Company) at
$0.04
per unit and (ii) establish toll processing arrangements with
two
toll processors of halloysite that, in management’s good faith belief, can process halloysite to the Company’s specifications. An additional
twenty-five
percent (
25%
) of the performance-based options vested on
February 1, 2018
when management generated
$900,000
of additional cash proceeds through (i) the sale of common stock and (ii) the licensing of a right to explore the Dragon Mine property for certain precious metals. The vesting of the remaining
8.3%,
8.3%
and
8.4%
of the performance-based options occurs when (i) EBITDA is positive over a
twelve
-month period, (ii) EBITDA is at or greater than
$2
million over a
twelve
-month period and (iii) EBITDA is at or greater than
$4
million over a
twelve
-month period, respectively. At
June 30, 2018,
the achievement of the performance targets was
not
deemed probable.
 
Compensation expense of
$192,299
and
$775,299
has been recognized for the vested options for the
three
and
six
months ended
June 30, 2018.
The aggregate intrinsic value of the outstanding options at
June 30, 2018
was
$4,114,914.
At
June 30, 2018, (
i)
$442,520
of unamortized compensation expense for time-based unvested options will be recognized over the next
0.53
years on a weighted average basis; and (ii)
$354,750
of unamortized compensation expense for performance-based unvested options will be recognized as the achievement of the performance targets becomes probable.
NOTE
10
– OPTIONS AND WARRANTS TO PURCHASE COMMON STOCK
 
Outstanding Stock Warrants
 
A summary of the status and changes of the warrants issued for
2017
and
2016
is as follows:
 
   
December 31, 2017
   
December 31, 2016
 
   
Shares issuable
upon exercise of
   
Weighted
Average
   
Shares issuable
upon exercise of
   
Weighted
Average
 
   
Outstanding
Warrants
   
Exercise
Price
   
Outstanding
Warrants
   
Exercise
Price
 
                                 
Outstanding at beginning of year
   
3,744,623
    $
0.36
     
461,340
    $
1.15
 
Issued
   
18,193,750
     
0.07
     
3,283,283
     
0.25
 
Exercised
   
(3,125,000
)
   
0.04
     
--
     
--
 
Forfeited
   
--
     
 
     
--
     
--
 
Outstanding at end of year
   
18,813,373
     
0.14
     
3,744,623
     
0.36
 
 
A summary of the status of the warrants outstanding and exercisable at
December 31, 2017
is presented below:
 
       
Warrants Outstanding and Exercisable
 
Exercise Price
   
Shares issuable
upon exercise of
Outstanding Warrants
   
Weighted Average
Remaining
Contractual Life (years)
   
Weighted
Average
Exercise Price
 
$ 1.15      
461,340
     
3.3
    $
1.15
 
$ 0.25      
3,283,283
     
3.5
    $
0.25
 
$ 0.04      
4,068,750
     
4.7
    $
0.04
 
$ 0.10      
11,000,000
     
5.0
    $
0.10
 
         
18,813,373
     
4.6
    $
0.14
 
 
During
June
of
2016,
the Company issued
10,933,333
units in exchange for
$1,640,000
in cash proceeds (
“June 2016
Offering”). Each unit consisted of
one
share of the Company’s common stock and
one
warrant to purchase
0.3
shares of the Company’s common stock for an equivalent price of
$0.25
per share.
 
During
August
and
October
of
2017,
the Company issued
26,500,000
units in exchange for
$1,060,000
in cash proceeds (
“August 2017
Offering”). The Company also issued
2,275,000
units to a broker as a fee related to the
August 2017
Offering. Each unit included
one
share of the Company’s common stock and
one
warrant to purchase
0.25
shares of the Company’s common stock for an equivalent price of
$0.04
per share. The purchase of
one
share of common stock requires the exercise of
four
warrants.
 
During
2017
investors exercised
12,500,000
warrants for
3,125,000
shares of the Company’s common stock. The exercise of the warrants generated
$125,000
of proceeds for the Company.
 
On
December 14, 2017,
upon the effectiveness of an amendment agreement the Company entered into by with the holders of the Series A Notes and Series
2023
Notes, the Company issued to the holders of the Series A Notes and Series
2023
Notes warrants to purchase
11,000,000
shares of the Company’s common stock. Each warrant enables a holder to purchase
one
share of the Company ‘s common stock for
$0.10.
The warrants expire on
December 13, 2022.
The Black Scholes value of the warrants totaled
$522,710
and was accounted for as a deferred cost of financing and presented as a discount to the Series A Notes and Series
2023
Notes.
 
Outstanding Stock Options
 
On
November 20, 2012,
the shareholders of the Company approved the adoption of the Applied Minerals, Inc.
2012
Long-Term Incentive Plan (“LTIP”) and the Short-Term Incentive Plan (“STIP”) and the performance criteria used in setting performance goals for awards intended to be performance-based. Under the LTIP,
8,900,000
shares are authorized for issuance. The STIP does
not
refer to a particular number of shares under the LTIP, but would use the shares authorized in the LTIP for issuance under the STIP. The CEO, the CFO, and named executive officers, and directors, among others are eligible to participate in the LTIP and STIP. Prior to the adoption of the LTIP and STIP, stock options were granted under individual arrangements between the Company and the grantees, and approved by the Board of Directors.
 
On
December 7, 2016,
the stockholders of the Company approved the
2016
Incentive Plan. The purpose of the
2016
Incentive Plan is to enhance the profitability and value of the Company for the benefit of its stockholders by enabling the Company to offer eligible employees, consultants, and non-employee directors incentive awards in order to attract, retain and reward such individuals and strengthen the mutuality of interests between such individuals and the Company’s stockholders. The aggregate number of shares of Common Stock that
may
be issued or used for reference purposes under the
2016
Incentive Plan or with respect to which awards
may
be granted
may
not
exceed 
15,000,000
shares, which
may
be either (i) authorized and unissued Common Stock or (ii) Common Stock held in or acquired for the treasury of the Company.
 
The Compensation Committee of the Company Board of Directors has full authority to administer and interpret the
2016
Incentive Plan, to grant awards under the
2016
Incentive Plan, to determine the persons to whom awards will be granted, to determine the types of awards to be granted, to determine the terms and conditions of each award, to determine the number of shares of Common Stock to be covered by each award and to make all other determinations in connection with the
2016
Incentive Plan and the awards thereunder as the Committee, in its sole discretion, deems necessary or desirable.
 
The fair value of each of the Company's stock option awards is estimated on the date of grant using the Black-Scholes option-pricing model that uses the assumptions noted in the table below. Expected volatility is based on an average of historical volatility of the Company's common stock. The risk-free interest rate for periods within the contractual life of the stock option award is based on the yield curve of a
zero
-coupon U.S. Treasury Bond on the date the award is granted with a maturity equal to the expected term of the award.
 
The significant assumptions relating to the valuation of the Company's options issued for
2017
and
2016
were as follows on a weighted average basis:
 
 
 
2017
 
 
2016
 
Dividend Yield  
 
0%
 
   
 
0%
 
 
Expected Life (in years)
 
2.50
6.27
 
 
2.00
9.02
 
Expected Volatility
 
114.98
167.28%
 
 
65.49
65.49%
 
Risk Free Interest Rate
 
1.38
2.26%
 
 
0.76
1.78%
 
 
A summary of the status and changes of the options granted under stock option plans and other agreements for
2017
and
2016
is as follows:
 
   
December 31, 2017
   
December 31, 2016
 
           
Weighted
           
Weighted
 
           
Average
           
Average
 
   
Shares
   
Exercise Price
   
Shares
   
Exercise Price
 
                                 
Outstanding at beginning of year
   
21,277,479
    $
0.87
     
17,806,472
    $
1.00
 
Granted
   
35,810,289
    $
0.06
     
3,771,488
     
0.24
 
Exercised
   
--
     
--
     
--
     
--
 
Forfeited
   
(30,000
)
   
 
     
(300,481
)
   
0.83
 
Outstanding at end of year
   
57,057,768
    $
0.36
     
21,277,479
    $
0.87
 
 
During the year ended
December 31, 2017,
the Company granted
35,810,289
options to purchase the Company’s common stock with a weighted average exercise price of
$0.06.
Of the
35,810,289
options granted, the options vest as follows:
 
 
 
Vesting Information
 
Shares
 
Frequency
 
Begin Date
 
End Date
 
350,000
 
Immediately
 
05/23/2017
 
05/23/2017
 
300,000
 
Immediately
 
05/24/2017
 
05/24/2017
 
100,000
 
Immediately
 
10/01/2017
 
10/01/2017
 
140,000
 
Immediately
 
12/07/2017
 
12/07/2017
 
6,875,000
 
Quarterly
 
10/01/2017
 
07/01/2018
 
545,289
 
Quarterly
 
10/01/2017
 
07/01/2018
 
27,500,000
 
Performance*
 
12/14/2017
 
12/14/2027
 
* On
December 14, 2017,
the Company’s management was granted performance-based options to purchase
27.5
million shares of the Company’s common stock at
$0.06
per share. The options expire on
December 13, 2027.
At
December 31, 2017,
the
first
 
fifty
percent (
50%
) of the performance-based options vested as management was able to (i) close the sale of an aggregate of
$600,000
of units (consisting of a share of common stock of the Company and a warrant to buy
0.25
of a share of common stock of the Company) at
$0.04
per unit and (ii) establish toll processing arrangements with
two
toll processors of halloysite that, in management’s good faith belief, can process halloysite to the Company’s specifications. An additional
twenty-five
percent (
25%
) of the performance-based options vested on
February 1, 2018
when management generated
$900,000
of additional cash proceeds through (i) the sale of common stock and (ii) the licensing of a right to explore the Dragon Mine property for certain precious metals. The vesting of the remaining
8.3%,
 
8.3%
and
8.4%
of the performance-based options occurs when (i) EBITDA is positive over a
twelve
-month period, (ii) EBITDA is at or greater than
$2
million over a
twelve
-month period and (iii) EBITDA is at or greater than
$4
million over a
twelve
-month period, respectively.
 
 
A summary of the status of the options outstanding at
December 31, 2017
is presented below:
 
Options Outstanding
 
 
Options Exercisable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average
 
 
Weighted
 
 
 
 
 
 
Weighted
 
 
 
 
Remaining
 
 
Average
 
 
 
 
 
 
Average
 
Number
 
 
Contractual
 
 
Exercise
 
 
Number
 
 
Exercise
 
Outstanding
 
 
Life (years)
 
 
Price
 
 
Exercisable
 
 
Price
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
34,475,000
 
 
 
9.95
 
 
$
0.06
 
 
 
15,568,718
 
 
$
0.06
 
545,289
 
 
 
9.98
 
 
$
0.075
 
 
 
45,289
 
 
$
0.075
 
500,000
 
 
 
3.62
 
 
$
0.16
 
 
 
500,000
 
 
$
0.16
 
81,395
 
 
 
6.14
 
 
$
0.21
 
 
 
40,698
 
 
$
0.21
 
100,000
 
 
 
2.71
 
 
$
0.22
 
 
 
100,000
 
 
$
0.22
 
1,066,155
 
 
 
3.36
 
 
$
0.24
 
 
 
1,066,155
 
 
$
0.24
 
2,087,500
 
 
 
4.79
 
 
$
0.25
 
 
 
2,087,500
 
 
$
0.25
 
35,595
 
 
 
5.29
 
 
$
0.27
 
 
 
17,798
 
 
$
0.27
 
474,815
 
 
 
6.36
 
 
$
0.28
 
 
 
362,408
 
 
$
0.28
 
234,506
 
 
 
5.13
 
 
$
0.285
 
 
 
234,506
 
 
$
0.285
 
81,522
 
 
 
3.05
 
 
$
0.30
 
 
 
40,716
 
 
$
0.30
 
200,000
 
 
 
7.12
 
 
$
0.66
 
 
 
200,000
 
 
$
0.66
 
150,000
 
 
 
7.10
 
 
$
0.68
 
 
 
99,990
 
 
$
0.68
 
7,233,277
 
 
 
0.99
 
 
$
0.70
 
 
 
7,233,277
 
 
$
0.70
 
488,356
 
 
 
7.38
 
 
$
0.73
 
 
 
371,666
 
 
$
0.73
 
3,104,653
 
 
 
4.15
 
 
$
0.83
 
 
 
3,104,653
 
 
$
0.83
 
975,000
 
 
 
6.45
 
 
$
0.84
 
 
 
975,000
 
 
$
0.84
 
300,000
 
 
 
5.64
 
 
$
1.10
 
 
 
300,000
 
 
$
1.10
 
300,000
 
 
 
5.48
 
 
$
1.15
 
 
 
300,000
 
 
$
1.15
 
100,000
 
 
 
0.08
 
 
$
1.24
 
 
 
100,000
 
 
$
1.24
 
115,000
 
 
 
3.24
 
 
$
1.35
 
 
 
115,000
 
 
$
1.35
 
125,000
 
 
 
0.08
 
 
$
1.45
 
 
 
125,000
 
 
$
1.45
 
300,000
 
 
 
4.40
 
 
$
1.55
 
 
 
300,000
 
 
$
1.55
 
7,645
 
 
 
0.09
 
 
$
1.58
 
 
 
7,645
 
 
$
1.58
 
3,077,060
 
 
 
4.89
 
 
$
1.66
 
 
 
3,077,060
 
 
$
1.66
 
900,000
 
 
 
3.63
 
 
$
1.90
 
 
 
900,000
 
 
$
1.90
 
57,057,768
 
 
 
7.45
 
 
$
0.36
 
 
 
37,273,079
 
 
$
0.52
 
 
Compensation expense of
$961,221,
and
$698,350,
has been recognized for the vested options for the years ended
December 31, 2017
and
2016,
respectively. The aggregate intrinsic value of the outstanding options at
December 31, 2017
was
$0.
At
December 31, 2017, (
i)
$303,522
of unamortized compensation expense for time-based unvested options will be recognized over the next
0.40
years on a weighted average basis; and (ii)
$709,500
of unamortized compensation expense for performance-based unvested options will be recognized as the performance targets are achieved.
 
On
December 14, 2017,
the Company’s management was granted performance-based options to purchase
27.5
million shares of the Company’s common stock at
$0.06
per share. The options expire on
December 13, 2027.
At
December 31, 2017,
the
first
fifty
percent (
50%
) of the performance-based options vested as management was able to (i) close the sale of an aggregate of
$600,000
of units (consisting of a share of common stock of the Company and a warrant to buy
0.25
of a share of common stock of the Company) at
$0.04
per unit and (ii) establish toll processing arrangements with
two
toll processors of halloysite that, in management’s good faith belief, can process halloysite to the Company’s specifications. An additional
twenty-five
percent (
25%
) of the performance-based options vested on
February 1, 2018
when management generated
$900,000
of additional cash proceeds through (i) the sale of common stock and (ii) the licensing of a right to explore the Dragon Mine property for certain precious metals. The vesting of the remaining
8.3%,
8.3%
and
8.4%
of the performance-based options occurs when (i) EBITDA is positive over a
twelve
-month period, (ii) EBITDA is at or greater than
$2
million over a
twelve
-month period and (iii) EBITDA is at or greater than
$4
million over a
twelve
-month period, respectively.